Narrativa and VMD Sciences team up on veterinary regulatory AI

Narrativa has partnered with VMD Sciences to automate veterinary regulatory documentation for global treatment importation across multiple countries and languages. The deal aims to cut drafting time, improve accuracy and help veterinarians move approved therapies through country-specific compliance steps faster.

Why it matters: - Veterinarians often need access to treatments approved in other countries to address unmet medical needs in animals. - Importing those treatments can require complex, country-specific regulatory documentation. - The partnership is designed to reduce manual work, improve consistency and speed up access to global treatment options.

What happened: - Narrativa partnered with VMD Sciences to deploy an AI-driven system for veterinary regulatory documentation. - The collaboration focuses on compliant importation of veterinary treatments across multiple countries and languages. - The announcement was made July 15, 2026.

The details: - Narrativa will use its agentic AI platform to automate creation of veterinary regulatory documents for different importation pathways. - The platform is built to handle structured data from patient records, clinical justifications and global product information. - The workflow supports multilingual document generation in the same process. - The system is designed to produce multiple drafts, support internal review and require human validation before final completion. - Narrativa says the platform helps improve data accuracy, reduce errors and align content across documents. - VMD Sciences said the goal is to generate highly regulated veterinary documentation with high data accuracy to support veterinarians accessing global treatments more efficiently. - Jennifer Bittinger, president at Narrativa, said the work helps teams reduce manual work and focus more on animal health.

Between the lines: - The deal points to a broader shift in regulated industries toward agentic AI tools that assist, rather than replace, human review. - Veterinary regulatory work appears to be a strong use case because it combines repetitive document creation with strict compliance requirements. - VMD Sciences’ role as a veterinary managed access provider gives the partnership a clear operational setting, not just a software pilot.

What's next: - Narrativa and VMD Sciences will apply the platform to regulatory documentation needed for importation cases. - The companies are likely to use the system to expand support for more countries, pathways and document types as needs grow. - Narrativa says its platform will continue to support speed, accuracy, consistency and compliance in regulated documentation.

The bottom line: - The partnership aims to make it faster and easier for veterinarians to access global treatments while keeping regulatory review and quality control in place.

More information is available from Narrativa and VMD Sciences.